New inhaler tested for deadly lung pressure disease
NCT ID NCT06129240
Summary
This study is testing the safety and side effects of a new dry powder inhaler version of a medication called treprostinil. It involves about 80 adults with pulmonary hypertension, a serious condition of high blood pressure in the lungs, often linked to lung scarring. The main goal is to see how well people tolerate this new inhaler device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health
Orlando, Florida, 32803, United States
-
Arizona Pulmonary Specialists
Phoenix, Arizona, 85012, United States
-
Houston Methodist
Houston, Texas, 77030, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
NYU Langone Medical Center
New York, New York, 10016, United States
-
National Jewish Health
Denver, Colorado, 80206, United States
-
Summit Health
Bend, Oregon, 97701, United States
-
Tampa General Hospital Center of Research Excellence
Tampa, Florida, 33606, United States
-
The Medical Research Group, Inc.
Fresno, California, 93720, United States
-
UC Davis
Sacramento, California, 95817, United States
-
UCLA Westwood
Los Angeles, California, 90095, United States
-
UCSF
San Francisco, California, 94143, United States
-
University of Cincinnati Health
Cincinnati, Ohio, 45219, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Rochester
Rochester, New York, 14627, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
-
Vincent Medical Group
Indianapolis, Indiana, 46260, United States
Conditions
Explore the condition pages connected to this study.